After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
RLAY belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Relay Therapeutics Inc is $1.28B. A total of 1.48 million shares were traded on the day, compared to an average of 1.88M shares.
In the most recent transaction, Catinazzo Thomas sold 10,780 shares of RLAY for 8.56 per share on Jul 29 ’24. After the transaction, the Chief Financial Officer now owns 319,650 company shares. In a previous transaction on Jul 30 ’24, Rahmer Peter sold 15,128 shares at 8.28 per share. RLAY shares that the insider owns now total 405,637.
Among the insiders who sold shares, Rahmer Peter disposed of 13,523 shares on Jul 29 ’24 at a per-share price of $8.54. This resulted in the insider holding 420,765 shares of RLAY after the transaction. In another insider transaction, Rahmer Peter sold 13,708 shares at $8.19 per share on Jul 31 ’24. Company shares held by the insider now total 391,929.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RLAY has a high of $12.14 and a low of $5.70.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $5.11, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.85.
